A carregar...
Co-Medication of Statins with Contraindicated Drugs
BACKGROUND: The concomitant use of cytochrome P450 3A4 (CYP3A4) metabolized statins (simvastatin, lovastatin, and atorvastatin) with CYP3A4 inhibitors has been shown to increase the rate of adverse events. OBJECTIVE: This study was performed to describe the co-medication prevalence of CYP3A4-metabol...
Na minha lista:
| Publicado no: | PLoS One |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4416887/ https://ncbi.nlm.nih.gov/pubmed/25932626 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0125180 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|